Global Pelvic Organ Prolapse Devices Market Size By Device (Vaginal Pessary, Vaginal Mesh), By Application (Surgical Devices, Non-Surgical Devices), By End-User (Hospitals, Ambulatory Surgical Centers), By Geographic Scope And Forecast
골반장기 탈출 장치 시장 규모와 예측
골반장기 탈출 기기 시장 규모는 2022년에 1억 8,536만 달러로 평가되었고, 2023년부터 2030년까지 연평균 복합 성장률(CAGR) 4.12%로 성장하여 2030년에는 4억 512만 달러에 달할 것으로 예측됩니다. 골반장기 탈출 장치 세계 시장 보고서는 시장의 전반적인 평가를 제공합니다.
골반장기 탈출 장치 세계 시장 정의
골반장기 탈출은 골반 영역의 지지 조직이나 근육이 약해지거나 느슨해진 후에 발생하는 질환입니다. 이 질환은 치료 가능하지만, 골반 장기 탈출 장치는 방광, 자궁, 소장, 질 중 일부를 포함한 골반 내장을 지원하기위한 것입니다.
방광 탈출은 방광류로 알려져 있습니다. 한편, 소장의 탈출은 장루라고 불립니다. 직장탈은 직장류라고 합니다. 이 장비는 외과 및 비 수술 도구와 같은 용도로 사용됩니다.
골반 장기 탈출 장치 세계 시장 개요
세계 노인 인구 증가와 고령화 여성 인구의 POP 유병률 증가가 예상되는 수년에 걸쳐 골반 장기 탈출 장치 시장을 견인할 것으로 기대됩니다. 성장은 지난 수십 년에 걸쳐 급격한 성장을 보였으며 예측 기간 동안 비슷한 경향을 보일 것으로 예상됩니다. 이것은 향후 몇 년간의 골반 장기 탈출 장치의 채용을 한층 더 보완할 것으로 예상됩니다. 여성에서 가장 흔한 질병 중 하나입니다. POP 환자의 약 37%는 60-70세, 절반 이상은 80세 이상입니다.
이에 더해 골반장기 탈출 치료에 있어서의 기술적 진보나 연구개발의 진행, 여성의 건강에 대한 의식의 고조가 향후 수년간 시장을 밀어올릴 것으로 예상됩니다. 억제요인이나 과제도 존재합니다.과학적인 유효성과 안전성의 부족, 수술에 드는 비용의 높이, 복잡한 규제 규범이나 기준 등의 요인은 수요를 어느 정도 제한합니다.
목차
제1장 골반장기 탈출 기기 세계 시장 : 소개
제2장 주요 요약
제3장 VERIFIED MARKET RESEARCH의 조사 방법
- 데이터 마이닝
- 밸리데이션
- 1차 인터뷰
- 데이터 소스 일람
제4장 골반장기 탈출 기기 세계 시장 전망
- 개요
- 시장 역학
- Porter's Five Forces 모델
- 밸류체인 분석
제5장 골반장기 탈출 기기 세계 시장 : 기기별
제6장 골반장기 탈출 기기 세계 시장 : 용도별
제7장 골반장기 탈출 기기 세계 시장 : 최종 사용자별
제8장 골반장기 탈출 기기 세계 시장 : 지역별
- 개요
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
- 아랍에미리트(UAE)
- 사우디아라비아
- 남아프리카
- 기타 중동 및 아프리카
제9장 골반장기 탈출 기기 세계 시장 : 경쟁 구도
제10장 기업 프로파일
- Johnson & Johnson Services, Inc.
- Coloplast Pty Ltd
- Boston Scientific Corporation
- CooperSurgical, Inc.
- Dr. Arabin GmbH & Co. KG
- Integra LifeSciences
- Utah Medical Products, Inc.
- Tic Med
- Cleo
- Shenzhen XFT Medical Limited
- Sunmedix Co, Ltd.
- Verity Medical Ltd
- Neomedic
- Medtronic
제11장 기업 프로파일 주요 발전
- 제품 출시/개발
- 합병과 인수
- 사업 확대
- 파트너십과 제휴
제12장 부록
JHS
Pelvic Organ Prolapse Devices Market Size And Forecast
Pelvic Organ Prolapse Devices Market size was valued at USD 185.36 Million in 2022 and is projected to reach USD 405.12 Million By 2030 , growing at a CAGR of 4.12% from 2023 to 2030. The increasing global geriatric population and rising prevalence of POP in the aging female population are expected to drive the Pelvic Organ Prolapse Devices Market over the predicted years. The Global Pelvic Organ Prolapse Devices Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Global Pelvic Organ Prolapse Devices Market Definition
Pelvic organ prolapse is a condition that occurs after the supporting tissues and muscles become weak or loose in the pelvic region. Though the disease is treatable, pelvic organ prolapse devices are meant to provide support to the pelvic organs including the bladder, uterus, small intestine, and part of the vagina.
The prolapse of the bladder is known as a cystocele. While prolapse of the small bowel is known as enterocele. If there's a prolapse of the rectum, it is known as a rectocele. The devices for pelvic organ prolapse are vaginal pessary and vaginal mesh. They are used in applications including Surgical Devices and Non-Surgical Devices. End-users of pelvic organ prolapse devices are Hospitals, Ambulatory Surgical Centers, and Others.
Global Pelvic Organ Prolapse Devices Market Overview
The increasing global geriatric population and rising prevalence of POP in the aging female population are expected to drive the Pelvic Organ Prolapse Devices Market over the predicted years. Besides this, the healthcare expenditure growth has witnessed exponential growth over the past couple of decades and it is expected to show the similar trend over the forecasted period. This will further complement the adoption of pelvic organ prolapse devices over the upcoming years. As per the data published by the World Health Organization, Pelvic organ prolapse is one of the most common in disease found across the women aged 60 to 69. Around 37% of the POP patients are between 60-70 years of age and more than half of the patients are more than 80 years of age.
In addition to this, technical advancements and ngoing research and developments in pelvic organ prolapse repair treatments and the growing awareness about women's health expect a boost to the market in the coming years.The ongoing investments and frequent need for the respective treatments will create substantial opportunities over the forecasted period. However, there are certain restraints and challenges faced which can hinder market growth. Factors such as lack of scientific efficacy & safety, higher costs involved in surgeries, and complex regulatory norms and standards will restrict the demand to some extent.
Global Pelvic Organ Prolapse Devices Market: Segmentation Analysis
The Global Pelvic Organ Prolapse Devices Market is Segmented on the basis of Device, Application, End-User, and Geography.
Pelvic Organ Prolapse Devices Market, By Device
- Vaginal Pessary
- Vaginal Mesh
Based on Device, the market is bifurcated into Vaginal Pessary and Vaginal Mesh. The Vaginal Pessary segment is expected to hold the largest market share. The factors can be attributed to a higher preference for vaginal pessary as vaginal mesh causes bleeding which are one of the most commonly found instances wherein the pelvic organ prolapse devices are generally used.
Pelvic Organ Prolapse Devices Market, By Application
- Surgical Devices
- Non-Surgical Devices
Based on Application, the market is bifurcated into Surgical Devices and Non-Surgical Devices. Surgical Devices are predicted to hold the most significant CAGR in the forecasted period as surgical devices are more effective than non-surgical devices in the treatment of pelvic organ prolapse. On the other hand, non surgical devices will also significant share considering the varying needs in line with the symptoms and medication instances.
Pelvic Organ Prolapse Devices Market, By End-User
- Hospitals
- Ambulatory Surgical Centers
- Others
Based on End-User, the market is bifurcated into Hospitals, Ambulatory Surgical Centers, and Others. Hospitals are anticipated to hold the largest market share. These factors can be credited to the higher rate of surgeries, growing treatment instances in the hospitals and lack of device applications in other clinics and ambulatory surgical centers. However, the ambulatory surgical centers will grow at the significant rate considering the rising awareness and ease of access.
Pelvic Organ Prolapse Devices Market, By Geography
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
- On the basis of regional analysis, the GlobalPelvic Organ Prolapse Devices Market is classified into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. North America led the Global Pelvic Organ Prolapse Devices Market in terms of growth, accounting for a sizable market share. The region is technologically advanced, and it was an early adoption of advanced healthcare technologies. Besides this, the strengthened healthcare infrastructure will further complement the market growth.
Key Players
- The "Global Pelvic Organ Prolapse Devices Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
- Johnson & Johnson Services, Inc., Coloplast Pty Ltd, Boston Scientific Corporation, CooperSurgical, Inc., Dr. Arabin GmbH & Co. KG, Integra LifeSciences, , Utah Medical Products, Inc., Tic Med, Cleo, Shenzhen XFT Medical Limited, Sunmedix Co, Ltd., Verity Medical Ltd, Neomedic, and Medtronic among others.
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
Key Developments
- In March 2020, the pelvic organ prolapse devices manufacturers, Fotofinder Zsystems Inc. has rebranded automated total body mapping systems as total body dermoscopy, allowing for immediate evaluation of dermoscopic structures of oles on full body photos.
- Ace Matrix Analysis
- The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as
- Active, Cutting Edge, Emerging, and Innovators.
- Market Attractiveness
- The image of market attractiveness provided would further help to get information about the region that is majorly leading in the global Pelvic Organ Prolapse Devices market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.
- Porter's Five Forces
- The image provided would further help to get information about Porter's five forces framework providing a blueprint for understanding the behavior of competitors and a player's strategic positioning in the respective industry. The porter's five forces model can be used to assess the competitive landscape in global Pelvic Organ Prolapse Devices market, gauge the attractiveness of a certain sector, and assess investment possibilities.
TABLE OF CONTENTS
1 INTRODUCTION OF GLOBAL PELVIC ORGAN PROLAPSE DEVICES MARKET
- 1.1 Overview of the Market
- 1.2 Scope of Report
- 1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
- 3.1 Data Mining
- 3.2 Validation
- 3.3 Primary Interviews
- 3.4 List of Data Sources
4 GLOBAL PELVIC ORGAN PROLAPSE DEVICES MARKET OUTLOOK
- 4.1 Overview
- 4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
- 4.3 Porters Five Force Model
- 4.4 Value Chain Analysis
5 GLOBAL PELVIC ORGAN PROLAPSE DEVICES MARKET, BY DEVICE
- 5.1 Overview
- 5.2 Vaginal Pessary
- 5.3 Vaginal Mesh
6 GLOBAL PELVIC ORGAN PROLAPSE DEVICES MARKET, BY APPLICATION
- 6.1 Overview
- 6.2 Surgical Devices
- 6.3 Non-Surgical Devices
7 GLOBAL PELVIC ORGAN PROLAPSE DEVICES MARKET, BY END-USER
- 7.1 Overview
- 7.2 Hospitals
- 7.3 Ambulatory Surgical Centers
- 7.4 Others
8 GLOBAL PELVIC ORGAN PROLAPSE DEVICES MARKET, BY GEOGRAPHY
- 8.1 Overview
- 8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest of Europe
- 8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
- 8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Argentina
- 8.5.3 Rest of LATAM
- 8.6 Middle East and Africa
- 8.6.1 UAE
- 8.6.2 Saudi Arabia
- 8.6.3 South Africa
- 8.6.4 Rest of the Middle East and Africa
9 GLOBAL PELVIC ORGAN PROLAPSE DEVICES MARKET COMPETITIVE LANDSCAPE
- 9.1 Overview
- 9.2 Company Market Ranking
- 9.3 Key Development Strategies
10 COMPANY PROFILES
- 10.1 Johnson & Johnson Services, Inc.
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
- 10.2 Coloplast Pty Ltd
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
- 10.3 Boston Scientific Corporation
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
- 10.4 CooperSurgical, Inc.
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
- 10.5 Dr. Arabin GmbH & Co. KG
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
- 10.6 Integra LifeSciences
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Developments
- 10.7 Utah Medical Products, Inc.
- 10.7.1 Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Outlook
- 10.7.4 Key Developments
- 10.8 Tic Med
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments
- 10.9 Cleo
- 10.9.1 Overview
- 10.9.2 Financial Performance
- 10.9.3 Product Outlook
- 10.9.4 Key Developments
- 10.10 Shenzhen XFT Medical Limited
- 10.10.1 Overview
- 10.10.2 Financial Performance
- 10.10.3 Product Outlook
- 10.10.4 Key Developments
- 10.11 Sunmedix Co, Ltd.
- 10.11.1 Overview
- 10.11.2 Financial Performance
- 10.11.3 Product Outlook
- 10.11.4 Key Developments
- 10.12 Verity Medical Ltd
- 10.12.1 Overview
- 10.12.2 Financial Performance
- 10.12.3 Product Outlook
- 10.12.4 Key Developments
- 10.13 Neomedic
- 10.13.1 Overview
- 10.13.2 Financial Performance
- 10.13.3 Product Outlook
- 10.13.4 Key Developments
- 10.14 Medtronic
- 10.14.1 Overview
- 10.14.2 Financial Performance
- 10.14.3 Product Outlook
- 10.14.4 Key Developments
11 KEY DEVELOPMENTS
- 11.1 Product Launches/Developments
- 11.2 Mergers and Acquisitions
- 11.3 Business Expansions
- 11.4 Partnerships and Collaborations
12 Appendix
